Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.
Press releases published on May 27, 2025
Liposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight
GlobeNewswire
·
May 27, 2025
New York, USA, May 27, 2025 (GLOBE NEWSWIRE) -- Liposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight The liposarcoma treatment market is driven by a rising global disease burden and …
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
GlobeNewswire
·
May 27, 2025
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced its intention to file a Form 25 Notification of Delisting with the Securities …
CARBIOS unterzeichnet erste Verträge über den Verkauf von biologisch recyceltem PET mit zwei weltweit führenden Kosmetikunternehmen
GlobeNewswire
·
May 27, 2025
CARBIOS hat zwei mehrjährige Verträge mit L'ORÉAL und L'Occitane en Provence über den Verkauf von enzymatisch recyceltem und recycelbarem PET aus seiner Anlage in Longlaville unterzeichnet und hat die Umsetzung seiner Strategie für die künftige Anlage …
CARBIOS signe ses premiers contrats de vente de PET biorecyclé avec deux leaders mondiaux de la cosmétique
GlobeNewswire
·
May 27, 2025
CARBIOS a signé deux contrats commerciaux pluriannuels de PET biorecyclé issu de l’usine de Longlaville, avec L’ORÉAL et L’Occitane en Provence et réalise une avancée dans l’exécution de sa stratégie pour sa future usine de Longlaville Ces premiers …
Avalo Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 27, 2025
WAYNE, Pa. and ROCKVILLE, Md., May 27, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that management will participate in the …
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense
GlobeNewswire
·
May 27, 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of …
Catheter Precision, Inc. Receives CE Mark for LockeT
GlobeNewswire
·
May 27, 2025
Opens Multi-Billion Market Opportunity for the Company First Order for 100 Units Received FORT MILL, S.C., May 27, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing …
30 years of Innovation and Impact: Dan Larson's Inspiring Story
GlobeNewswire
·
May 27, 2025
SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that …
New Survey Shows Physician Appointment Wait Times Surge: 19% Since 2022, 48% Since 2004
GlobeNewswire
·
May 27, 2025
DALLAS, May 27, 2025 (GLOBE NEWSWIRE) -- The time required to schedule a physician appointment in 15 major metropolitan areas has increased by 19% since 2022 and by 48% since 2004, according to a new survey conducted by AMN Healthcare, the nation's leading …
Forte Medical Revolutionises Women’s Routine Health with Peezy Midstream
GlobeNewswire
·
May 27, 2025
LONDON, May 27, 2025 (GLOBE NEWSWIRE) -- Forte Medical, the UK’s leading specialist in urine collection technology, today announces the launch of new Peezy Midstream. This pioneering device transforms routine urinary tract infection (UTI) and antenatal …
VIVUS Announces QSYMIA® Now Available at Costco Pharmacies Nationwide
GlobeNewswire
·
May 27, 2025
— Expanded retail access aims to enhance overweight or obesity treatment accessibility CAMPBELL, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that …
Altamira Therapeutics Announces Collaboration on Circular RNA Delivery
GlobeNewswire
·
May 27, 2025
Hamilton, May 27, 2025 (GLOBE NEWSWIRE) -- Exploring use of Altamira’s RNA nanoparticles in conjunction with circular RNA payloads Project collaboration partner will have option to negotiate licensing agreement Altamira Therapeutics Ltd. (“Altamira” or the …
HiberCell Announces Successful Completion of Dose Escalation and Enrollment Update for Ph1b Study Evaluating HC-7366 in Combination with WELIREG® (belzutifan) in Advanced ccRCC
GlobeNewswire
·
May 27, 2025
BOSTON, May 27, 2025 (GLOBE NEWSWIRE) -- HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis, and resistance, today announced the successful completion of the dose escalation portion of its …
Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu
GlobeNewswire
·
May 27, 2025
Dallas, TX, May 27, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under …
AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders
GlobeNewswire
·
May 27, 2025
Research Triangle Park, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- AB-1005 was well tolerated with no attributed serious adverse events in participants with mild or moderate Parkinson’s disease (PD) through 18 months post-gene transfer Non-motor assessments …
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting
GlobeNewswire
·
May 27, 2025
ROCHESTER, N.Y., May 27, 2025 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and Alzheimer’s disease (AD) through the inhibition of Semaphorin 4D (SEMA4D), …
Iolyx Therapeutics Announces Phase 2 Results for ILYX-002 in Autoimmune Dry Eye Disease
GlobeNewswire
·
May 27, 2025
Results shared during a R…
SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System
GlobeNewswire
·
May 27, 2025
FORT LAUDERDALE, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and …
Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis
GlobeNewswire
·
May 27, 2025
Study met its primary endpoints of safety, tolerability, and pharmacokinetics (PK) No serious adverse events (SAEs) or treatment-emergent adverse events (TEAEs) related to laboratory values or EKGs observed across SAD/MAD cohorts Management releases a “ …
Strongline returns to market, signs deal with QLog to ensure leading staff duress offering is available to health systems around the country
GlobeNewswire
·
May 27, 2025
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- Commure announced today a strategic partnership and licensing agreement with QLog, a leading Israeli innovator in real-time location systems (RTLS) and Bluetooth Low Energy (BLE) technologies for healthcare. …